Cargando…

An effective strategy for recapitulating N-terminal heptad repeat trimers in enveloped virus surface glycoproteins for therapeutic applications

Sequestering peptides derived from the N-terminal heptad repeat (NHR) of class I viral fusion proteins into a non-aggregating trimeric coiled-coil conformation remains a major challenge. Here, we implemented a synthetic strategy to stabilize NHR-helical trimers, with the human immunodeficiency virus...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Wenqing, Wang, Chao, Yu, Fei, Lu, Lu, Wang, Qian, Jiang, Xifeng, Xu, Xiaoyu, Zhang, Tianhong, Wu, Shengming, Zheng, Xi, Zhang, Zhenqing, Dong, Fangting, Jiang, Shibo, Liu, Keliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal Society of Chemistry 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968561/
https://www.ncbi.nlm.nih.gov/pubmed/29899942
http://dx.doi.org/10.1039/c5sc04046a
_version_ 1783325794063351808
author Lai, Wenqing
Wang, Chao
Yu, Fei
Lu, Lu
Wang, Qian
Jiang, Xifeng
Xu, Xiaoyu
Zhang, Tianhong
Wu, Shengming
Zheng, Xi
Zhang, Zhenqing
Dong, Fangting
Jiang, Shibo
Liu, Keliang
author_facet Lai, Wenqing
Wang, Chao
Yu, Fei
Lu, Lu
Wang, Qian
Jiang, Xifeng
Xu, Xiaoyu
Zhang, Tianhong
Wu, Shengming
Zheng, Xi
Zhang, Zhenqing
Dong, Fangting
Jiang, Shibo
Liu, Keliang
author_sort Lai, Wenqing
collection PubMed
description Sequestering peptides derived from the N-terminal heptad repeat (NHR) of class I viral fusion proteins into a non-aggregating trimeric coiled-coil conformation remains a major challenge. Here, we implemented a synthetic strategy to stabilize NHR-helical trimers, with the human immunodeficiency virus type 1 (HIV-1) gp41 fusion protein as the initial focus. A set of trimeric scaffolds was realized in a synthetic gp41 NHR-derived peptide sequence by relying on the tractability of coiled-coil structures and an additional isopeptide bridge-tethering strategy. Among them, (N36M)(3) folded as a highly stable helical trimer and exhibited promising inhibitory activity against HIV-1 infection, exceptional resistance to proteolysis, and effective native ligand-binding capability. We anticipate that the trimeric coiled-coil recapitulation methodology described herein may have broader applicability to yield NHR trimers of other class I enveloped viruses and to prepare helical tertiary structure mimetics of certain natural protein–protein interactions for biomedical applications.
format Online
Article
Text
id pubmed-5968561
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-59685612018-06-13 An effective strategy for recapitulating N-terminal heptad repeat trimers in enveloped virus surface glycoproteins for therapeutic applications Lai, Wenqing Wang, Chao Yu, Fei Lu, Lu Wang, Qian Jiang, Xifeng Xu, Xiaoyu Zhang, Tianhong Wu, Shengming Zheng, Xi Zhang, Zhenqing Dong, Fangting Jiang, Shibo Liu, Keliang Chem Sci Chemistry Sequestering peptides derived from the N-terminal heptad repeat (NHR) of class I viral fusion proteins into a non-aggregating trimeric coiled-coil conformation remains a major challenge. Here, we implemented a synthetic strategy to stabilize NHR-helical trimers, with the human immunodeficiency virus type 1 (HIV-1) gp41 fusion protein as the initial focus. A set of trimeric scaffolds was realized in a synthetic gp41 NHR-derived peptide sequence by relying on the tractability of coiled-coil structures and an additional isopeptide bridge-tethering strategy. Among them, (N36M)(3) folded as a highly stable helical trimer and exhibited promising inhibitory activity against HIV-1 infection, exceptional resistance to proteolysis, and effective native ligand-binding capability. We anticipate that the trimeric coiled-coil recapitulation methodology described herein may have broader applicability to yield NHR trimers of other class I enveloped viruses and to prepare helical tertiary structure mimetics of certain natural protein–protein interactions for biomedical applications. Royal Society of Chemistry 2016-03-01 2015-12-03 /pmc/articles/PMC5968561/ /pubmed/29899942 http://dx.doi.org/10.1039/c5sc04046a Text en This journal is © The Royal Society of Chemistry 2016 http://creativecommons.org/licenses/by/3.0/ This article is freely available. This article is licensed under a Creative Commons Attribution 3.0 Unported Licence (CC BY 3.0)
spellingShingle Chemistry
Lai, Wenqing
Wang, Chao
Yu, Fei
Lu, Lu
Wang, Qian
Jiang, Xifeng
Xu, Xiaoyu
Zhang, Tianhong
Wu, Shengming
Zheng, Xi
Zhang, Zhenqing
Dong, Fangting
Jiang, Shibo
Liu, Keliang
An effective strategy for recapitulating N-terminal heptad repeat trimers in enveloped virus surface glycoproteins for therapeutic applications
title An effective strategy for recapitulating N-terminal heptad repeat trimers in enveloped virus surface glycoproteins for therapeutic applications
title_full An effective strategy for recapitulating N-terminal heptad repeat trimers in enveloped virus surface glycoproteins for therapeutic applications
title_fullStr An effective strategy for recapitulating N-terminal heptad repeat trimers in enveloped virus surface glycoproteins for therapeutic applications
title_full_unstemmed An effective strategy for recapitulating N-terminal heptad repeat trimers in enveloped virus surface glycoproteins for therapeutic applications
title_short An effective strategy for recapitulating N-terminal heptad repeat trimers in enveloped virus surface glycoproteins for therapeutic applications
title_sort effective strategy for recapitulating n-terminal heptad repeat trimers in enveloped virus surface glycoproteins for therapeutic applications
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968561/
https://www.ncbi.nlm.nih.gov/pubmed/29899942
http://dx.doi.org/10.1039/c5sc04046a
work_keys_str_mv AT laiwenqing aneffectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications
AT wangchao aneffectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications
AT yufei aneffectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications
AT lulu aneffectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications
AT wangqian aneffectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications
AT jiangxifeng aneffectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications
AT xuxiaoyu aneffectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications
AT zhangtianhong aneffectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications
AT wushengming aneffectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications
AT zhengxi aneffectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications
AT zhangzhenqing aneffectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications
AT dongfangting aneffectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications
AT jiangshibo aneffectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications
AT liukeliang aneffectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications
AT laiwenqing effectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications
AT wangchao effectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications
AT yufei effectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications
AT lulu effectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications
AT wangqian effectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications
AT jiangxifeng effectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications
AT xuxiaoyu effectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications
AT zhangtianhong effectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications
AT wushengming effectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications
AT zhengxi effectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications
AT zhangzhenqing effectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications
AT dongfangting effectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications
AT jiangshibo effectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications
AT liukeliang effectivestrategyforrecapitulatingnterminalheptadrepeattrimersinenvelopedvirussurfaceglycoproteinsfortherapeuticapplications